Lockheed Martin-backed Tempo Automation sealed its reverse merger while Strand Therapeutics upped a round featuring Eli Lilly and Beigene to $97m.

Courtesy of Pexels

Public markets

Tempo Automation, a US-based industrial automation software provider that counts aerospace manufacturer Lockheed Martin as an investor, completed its reverse merger with special purpose acquisition company Ace Convergence Acquisition Corp and is now listed on the Nasdaq market. It agreed the $919m deal in October 2021.

Funding

Company name Company description Sector Country Round Round Size ($) Deal date Investors
Strand Therapeutics  Programmable mRNA therapy developer Healthcare US A 97 (updated) 29/11/2022 Eli…

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
Events
GCV Connect: Korea 2024
Dec 10 -
Dec 12, 2024
Seoul (South Korea)
Events
GCV Institute: CVC Investment Programs
Jan 28 -
Jan 29, 2025
Online
Events
GCV Institute: CVC Investment Programs
Mar 17 -
Mar 18, 2025
Palo Alto, CA (USA)
Events
GCVI Summit 2025
Mar 18 -
Mar 20, 2025
Monterey, CA (USA)
Events
GCV Institute: Landing the Value of Corporate Venturing
May 1 -
May 6, 2025
Online
Events
GCV Symposium 2025
Jun 17 -
Jun 19, 2025
London (UK)
© 2024 Mawsonia Ltd. All rights reserved.
test reg